International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors

Pharmacological Reviews

Volumn 50, Issue 2, 1998, Pages 279-290

  Caulfield, Malcolm P ^a   Birdsall, Nigel J M ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,6A,11,14 TETRAHYDRO 9 METHOXY 2 METHYL 12H ISOQUINO[1,2 B]PYRROLO[3,2 F][1,3]BENZOXAZINE 1 CARBOXYLIC ACID ETHYL ESTER; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; ATROPINE; DARIFENACIN; HIMBACINE; METHOCTRAMINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; PIRENZEPINE; RECEPTOR SUBTYPE; SNAKE VENOM; TRIPITRAMINE; UNCLASSIFIED DRUG;

ALLOSTERISM; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; CLASSIFICATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TERTIARY STRUCTURE; RECEPTOR AFFINITY; RECEPTOR GENE; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ANIMALS; HUMANS; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION;

EID: 0031774720     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (150)

1. Adem A and Karlson E (1997) Muscarinic receptor subtype selective toxins. Life Sci 60:1069-1076.
2. Ashkenazi A, Winslow JW, Peralta EG, Peterson GL, Schimerlik MI, Capon DJ and Ramachandran J (1987) An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science 238:672-675.
3. Baldwin JM (1993) The probable arrangement of the helices in G protein coupled receptors. EMBO J 12:1693-1703.
4. Baldwin JM, Schertler GF and Unger VM (1997) An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol 272:144-164.
5. Barlow RB, Berry KJ, Glenton PAM, Nikolau NM and Soh KS (1976) A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea-pig atrial pacemaker cells at 29°C and in ileum at 29°C and 37°C. Br J Pharmacol 58:613-620.
6. Bernard V, Normand E and Bloch B (1992) Phenotypical characterization of the rat striatal neurons expressing muscarinic receptors. J Neurosci 12:3591-3600.
7. 2+ current and M current in rat sympathetic neurons. Proc Natl Acad Sci USA 89:9544-9548.
8. Birdsall NJM, Farries T, Gharagozloo P, Kobayashi S, Kuonen D, Lazareno S, Popham A and Sugimoto M (1997) Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes. Lift Sci 60:1047-1052.
9. Birdsall NJM and Hulme EC (1983) Muscarinic receptor subclasses. Trends Pharmacol Sci 4:459-463.
10. Birdsall NJM, Hulme EC, Kromer W and Stockton JM (1987) A second drug-binding site on muscarinic receptors. Fed Proc 46:2525-2527.
11. q/11 by the m3 muscarinic acetylcholine receptor. J Biol Chem 270:17741-17748.
12. Blüml K, Mutschler E and Wess J (1994) Functional role in ligand binding and receptor activation of an asparagine residue present in the sixth transmembrane domain of all muscarinic acetylcholine receptors. J Biol Chem 269:18870-18876.
13. 3 muscarinic receptors. Life Sci 60:1121-1128.
14. Bonner TI, Buckley NJ, Young AC and Brann MR (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237:527-532.
15. Bonner TI, Modi WS, Seuanez HN, O'Brien SJ (1991) Chromosomal mapping of the five human genes encoding muscarinic acetylcholine receptors. Cytogenet Cell Genet 58:1850-1851.
16. Bonner TI, Young AC, Brann MR and Buckley NJ (1988) Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1:403-410.
17. + channels, in Molecular Mechanisms of Muscarinic Acetylcholine Receptor Function (Wess J ed) pp 165 182, R. G. Landes, Austin.
18. Brown DA, Forward A and Marsh S (1980) Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br J Pharmacol 71:362-364.
19. Buckley NJ, Bonner TI, Buckley CM and Brann MR (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35:469-476.
20. Burstein ES, Spalding TA and Brann MR (1997) Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins. Mol Pharmacol 51:312-319.
21. Burstein ES, Spalding TA, Brauner-Osborne H and Brann MR (1995) Constitutive activity of muscarinic receptors by the G-protein Gq. FEBS Lett 363:261-263.
22. Caulfield MP (1997) Muscarinic receptor classification, in Muscarinic Receptor Subtypes in Smooth Muscle (Eglen RM ed) pp 1-37, CRC Press, New York.
23. Caulfield MP (1993) Muscarinic receptors: Characterization, coupling and function. Pharmacol Ther 58:319-379.
24. Clark AL and Mitchelson F (1976) The inhibitory effect of gallamine on muscarinic receptors. Br J Pharmacol 58:323-331.
25. Curtis CAM and Hulme EC (1997) Over-expression and purification of engineered M1 muscarinic receptors (abstract). Life Sci 60:1176.
26. Curtis CA, Wheatley M, Bansal S, Birdsall NJM, Eveleigh P, Pedder EK, Poyner D and Hulme EC (1989) Propylbenzilylcholine mustard labels an acidic residue in transmembrane helix 3 of the muscarinic receptor (abstract). J Biol Chem 264: 489-495.
27. Darroch SA, Choo LK and Mitchelson F (1992) Prejunctional muscarine receptors in the rabbit ear artery differ from M1, M2 and M3 muscarine receptors. Naunyn Schmiedebergs Arch Pharmacol 345:288-295.
28. Dittman AH, Weber JP, Hinds TR, Choi E-J, Migeon JC, Nathanson NM and Storm DR (1994) A novel mechanism for coupling of m4 muscarinic acetylcholine receptors to calmodulin-sensitive adenylyl cyclases: Crossover from G protein-coupled inhibition to stimulation. Biochemistry 33:943-951.
29. Dörje F, Levey A and Brenn MR (1991a) Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues. Mol Pharmacol 40:459-462.
30. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E and Brann MR (1991b) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727-733.
31. Eglen RM, Hegde SS and Watson N (1996) Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 48:531-565.
32. Eglen RM, Reddy H, Watson N and Challiss RAJ (1994) Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol Sci 15:114-119.
33. Eglen RM and Whiting RL (1990) Heterogeneity of vascular muscarinic receptors. J Auton Pharmacol 10:233-245.
34. Eglen RM and Whiting RL (1996) Selective muscarinic receptor agonists and antagonists. Pharmacol Toxicol 78:59-78.
35. Ehlert FJ (1988) Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium. J Pharmacol Exp Ther 247:596-602.
36. Ellis J, Huyler J and Brann MR (1991) Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Biochem Pharmacol 42:199-205.
37. Ellis J, Seidenberg M and Brann MR (1993) Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol Pharmacol 44:583-588.
38. Eltze M (1988) Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur J Pharmacol 151:205-221.
39. Ensinger HA, Doods HN, Immel-Sehr AR, Kuhn FJ, Lambrecht G, Mendla KD, Muller RE, Mutschler E, Sagrada A, Walther G and Hammer R (1993) WAL 2014: A muscarinic agonist with preferential neuron-stimulating properties. Life Sci 52:473-480.
40. Felder CC (1995) Muscarinic acetylcholine receptors: Signal transduction through multiple effectors. FASEB J 9:619-625.
41. 1 agonists in the treatment of Alzheimer's disease: Novel properties and clinical update. Ann N Y Acad Sci 777:189-196.
42. Flynn DD, Reever CM and Ferrari-Dileo G (1995) Pharmacological strategies to selectively label and localize muscarinic receptor subtypes Drug Dev Res 40:104-116.
43. Freedman SB, Dawson GR, Iversen LL, Baker R and Hargreaves RJ (1993) The design of novel partial muscarinic agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo. Life Sci 52:489-495.
44. Fuder H and Muscholl E (1995) Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves. Rev Physiol Biochem Pharmacol 126:265-412.
45. 1 muscarinic receptors increase calcium current and phosphoinositide turnover in guinea-pig ventricular cardiocytes. J Physiol 471:41-60.
46. Grimm U, Fuder H, Moser U, Bäumert HG, Mutschler E and Lambrecht G (1994a) Characterisation of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in the rabbit vas deferens. Naunyn Schmiedebergs Arch Pharmacol 349:1-10.
47. Grimm U, Moser U, Mutschler E and Lambrecht G (1994b) Muscarinic receptors: Focus on presynaptic mechanisms and recently developed novel agonists and antagonists. Pharmazie 49:711-726.
48. 4 receptors mediating nonadrenergic noncholinergic relaxations in rabbit anococcygeus muscle. Naunyn Schmiedebergs Arch Pharmacol 356:505-516.
49. Gurwitz D, Haring R, Heldman E, Fraser CM, Manor D and Fisher A (1994) Discrete activation of transduction pathways associated with acetylcholine m1 receptor by aeveral muscarinic ligands. Eur J Pharmacol 267:21-31.
50. Hall JM, Caulfield MP, Watson SP and Guard S (1993) Receptor subtypes or species homologues: Relevance to drug discovery. Trends Pharmacol Sci 14:376-383.
51. Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McNight GS, Idzerda RL and Nathanson NM (1997) Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci USA 94:13311-13316.
52. Hammer R, Berrie CP, Birdsall NJM, Burgen ASV and Hulme EC (1980) Pirenzepine distinguishes between subclasses of muscarinic receptors. Nature 283:90-92.
53. 2 biochemical and functional characterization. Life Sci 31:2991-2998.
54. Hayashi MK and Haga T (1997) Palmitoylation of muscarinic acetylcholine receptor m2 subtypes: Reduction in their ability to activate G proteins by mutation of a putative palmitoylation site, cysteine 457, in the carboxyl-terminal tail. Arch Biochem Biophys 340:376-382.
55. Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E and Downing KH (1990) Model for the structure of bacteriorhodopsin based on high-resolution electron cryomicroscopy. J Mol Biol 213:899-929.
56. Hepler JR, Biddlecombe GH, Kleuss C, Camp LA, Hofmann SL, Ross EM and Gilman AG (1996) Functional importance of the amino terminus of Gq alpha. J Biol Chem 271:496-504.
57. Herrera L, Carvallo P, Antonelli M and Olate J (1994) Cloning of a Xenopus laevis muscarinic receptor encoded by an intronless gene. FEBS Lett 352:175-179.
58. Hersch SM and Levey AI (1995) Diverse pre- and post-synaptic expression of m1-m4 muscarinic receptor proteins in neurons and afferents in the rat neostriatum. Life Sci 56:931-938.
59. Hon X, Wehrle J, Menge W, Ciccarelli E, Wess J, Mutschler E, Lambrecht G, Timmerman H and Waelbroeck M (1996) Influence of monovalent cations on the binding of a charged and an uncharged ('carbo') muscarinic antagonist to muscarinic receptors. Br J Pharmacol 117:955-961.
60. Huang HJ, Liao CF, Yang BC and Kuo TT (1992) Functional expression of rat M5 muscarinic acetylcholine receptor in yeast. Biochem Biophys Res Commun 182: 1180-1186.
61. Hulme EC, Berne CP, Birdsall NJM and Burgen ASV (1981) Two populations of binding sites for muscarinic antagonists in the rat heart. Eur J Pharmacol 73:137-142.
62. Hulme EC and Birdsall NJM (1992) Strategy and tactics in receptor binding studies, in Receptor Ligand Interactions: A Practical Approach (Hulme EC ed) pp 63-176, Oxford University Press, New York.
63. Hulme EC, Birdsall NJM and Buckley NJ (1990) Muscarinic receptor subtypes. Ann Rev Pharmacol Toxicol 30:633-673.
64. Jaen J, Barrett S, Brann M, Callahan M, Davis R, Doyle P, Eubanks D, Lauffer L, Lipinski W, Moreland D, Nelson C, Raby C, Schwarz R, Spencer C and Tecle H (1995) In vitro and in vivo evaluation of the subtype-selective agonist PD 151832. Life Sci 56:845-852.
65. Jakubik J, Bacakova L, El-Fakahany EE and Tucek S (1997) Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic receptors. Mol Pharmacol 52:172-179.
66. Jerusalinsky D and Harvey AL (1994) Toxins from mamba venoms: Small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. Trends Pharmacol Sci 15:424-430.
67. Jolkkonen M, Van Giersbergen PLM, Hellman U, Wernstedt C and Karlsson E (1994) A toxin from the green mamba Dendroaspis angusticeps: Amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett 352:91-94.
68. 1 receptor. Eur J Pharmacol 288:251-257.
69. Kenakin TP (1996) The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48:413-463.
70. Kenakin TP and Boselli C (1990) Promiscuous or heterogeneous muscarinic receptors in rat atria? I. Schild analysis with simple competitive antagonists. Eur J Pharmacol 191:39-48.
71. 2. J Biol Chem 271:17476-17484.
72. Kubo T, Fukuda K, Mikami A, Maeda A, Takahashi H, Mishina M, Haga T, Haga K, Ichiyama A, Kangawa K, Kojima M, Matsuo H, Hirose T and Numa S (1986a) Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature 323:411-416.
73. Kubo T, Maeda A, Sugimoto K, Akiba I, Mikami A, Takahashi H, Haga T, Haga K, Ichiyama A, Kangawa K, Matsuo H, Hirose T and Numa S (1986b) Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence. FEBS Lett 209:367-372.
74. Kurtenbach E, Curtis CA, Pedder EK, Aitken A, Harris AC and Hulme EC (1990) Muscarinic acetylcholine receptors: Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. J Biol Chem 265: 13702-13708.
75. Lambrecht G, Moser U, Grimm U, Hermann U, Hilderbrandt C, Waelbroeck M, Christophe J and Mutschler E (1993) New functionally selective muscarinic agonists. Life Sci 52:481-486.
76. Lambrecht G, Pfaff O, Aasen AJ, Sjö P, Mutschler E and Waelbroeck M (1997) Stereoselective interaction of p-fluoro-trihexyphenidyl and its methiodide with four muscarinic receptor subtypes (abstract). Life Sci 60:1166.
77. Lazareno S and Birdsall NJM (1995) Detection, quantitation and verification of allosteric interactions of agents with labelled and unlabelled ligands at G protein-coupled receptors: Interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48:362-378.
78. Lazareno S and Birdsall NJM (1993a) Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations. Br J Pharmacol 109:1110-1119.
79. 35s]-Gtpgammas binding mediated by human muscarinic m1-m4 receptors: Antagonist studies. Br J Pharmacol 109:1120-1127.
80. 4 binding sites in rabbit lung, chicken heart and NG108-15 cells. Mol Pharmacol 53:573-589. 38:805-815.
81. Lazareno S, Farries T and Birdsall NJM (1993) Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors M1-M4. Life Sci 52:449-456.
82. Lazareno S, Gharagozloo P, Kuonen D, Popham A and Birdsall NJM (1998) Subtype selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: Radioligand binding studies. Mol Pharmacol, 53:573-589.
83. Lee NH and El-Fakahany EE (1991) Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem Pharmacol 42:199-205.
84. Leppik RA, Miller RC, Eck M and Pacquet J-L (1994) Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor. Mol Pharmacol 45:983-990.
85. Levey AI (1993) Immunological localization of m1-m5 muscarinic receptor subtypes in peripheral tissues and brain. Life Sci 52:441-448.
86. Levine RR and Birdsall NJM (eds) (1989) Subtypes of muscarinic receptors: Proceedings of the 4th international symposium on subtypes of muscarinic receptors. Trends Pharmacol Sci 10(Suppl 7):S1-S119.
87. Levine RR and Birdsall NJM (eds) (1997) Subtypes of muscarinic receptors. Proceedings of the 7th international symposium on subtypes of muscarinic receptors. Life Sci 60:963-1207.
88. Li M, Yasuda RP, Wall SJ, Wellstein A and Wolfe BB (1991) Distribution of m2 muscarinic receptors in rat brain using antisera selective for m2 receptors. Mol Pharmacol 40:28-35.
89. Liu J, Conklin BR, Blin N, Yun J and Wess J (1995) Identification of a receptor/G protein contact site critical for signaling specificity and G protein activation. Proc Natl Acad Sci USA 92:11642-11646.
90. Lu Z-L, Curtis CA, Jones PG, Pavia J and Hulme EC (1997) The role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: Mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling. Mol Pharmacol 51:234-241.
91. Maggio R, Barbier P, Bolognesi ML, Minarini A, Tedeschi D and Melchiorre C (1994) Binding profile of the selective muscarinic receptor antagonist tripitramine. Eur J Pharmacol 268:459-462.
92. Marrion NV, Smart TG, Marsh SJ and Brown DA (1989) Muscarinic suppression of the M-current in the rat sympathetic ganglion is mediated by receptors of the M1-subtype. Br J Pharmacol 98:557-573.
93. Marsh SJ, Trouslard J, Leaney J and Brown DA (1995) Synergistic regulation of a neuronal chloride current by intracellular calcium and muscarinic receptor activation: A role for protein kinase C. Neuron 15:729-737.
94. Matsui H, Lazareno S and Birdsall NJM (1995) Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. Mol Pharmacol 47:88-98.
95. Méry P-F, Abi-Gerges N, Nandecasteele G, Jurevicius J, Eschenhagen T and Fischmeister R (1997) Muscarinic regulation of the L-type calcium current in isolated cardiac myocytes. Life Sci 60:1113-1120.
96. Micheletti R, Giudici L, Turconi M and Donetti A (1990a) 4-DAMP analogues reveal heterogeneity of M1 muscarinic receptors. Br J Pharmacol 100:395-397.
97. Micheletti R, Schiavone A, Angelici O, Duranti P, Giudici L, Cereda E and Donetti A (1990b) Affinity profile of the novel muscarinic antagonist guanylpirenzepine. Life Sci 47:55-58.
98. Micheletti R, Schiavone A and Giachetti A (1988) Muscarinic M1 receptors stimulate a nonadrenergic noncholinergic inhibitory pathway in the isolated rat duodenum. J Pharmacol Exp Ther 244:680-684.
99. Mita Y, Dobashi K, Susuki K, Mori M and Nakazawa T (1996) Induction of muscarinic receptor subtypes in monocytic/macrophagic cells differentiated from EoL-1 cells. Eur J Pharmacol 297:121-127.
100. Nunn PA, Greengrass PM, Newgreen DT, Naylor AM and Wallis RM (1996) The binding profile of the novel muscarinic receptor antagonist darifenacin against the five cloned human muscarinic receptors expressed in CHO cells (abstract). Br J Pharmacol 117:130P.
101. Olianas MC, Adem A, Karlsson E and Onali P (1996) Rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity: Potent block by the selective m4 ligand muscarinic toxin 3 (MT3). Br J Pharmacol 118:283-288.
102. Onai T, FitzGerald MG, Arakawa S, Gocayne JD, Urquhart DA, Hall LM, Fraser CM, McCombie WR and Venter JC (1989) Cloning, sequence analysis and chromosome localization of a Drosophila muscarinic acetylcholine receptor. FEBS Lett 255:219-225.
103. Onali P and Olianas MC (1995) Bimodal regulation of cyclic AMP by muscarinic receptors: Involvement of multiple G proteins and different forms of adenylyl cyclase. Life Sci 56:973-980.
104. O'Rourke ST and Vanhoutte PM (1987) Subtypes of muscarinic receptors on adrenergic nerves and vascular smooth muscle of the canine saphenous vein. J Pharmacol Exp Ther 241:64-67.
105. Pals-Rylaarsdam R and Hosey MM (1997) Two homologous phosphorylation domains differentially contribute to desensitization and internalization of the m2 muscarinic acetylcholine receptor. J Biol Chem 272:14152-14158.
106. Payette P, Gossard F, Whiteway M and Dennis M (1990) Expression and pharmacological characterization of the human Ml muscarinic receptor in Saccharomyces cerevisiae. FEBS Lett 266:21-25.
107. Pedder EK, Eveleigh P, Poyner D, Hulme EC and Birdsall NJM (1991) Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes. Br J Pharmacol 103:1561-1567.
108. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J and Capon DJ (1987) Distinct primary structures, ligand binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J 6:3923-3929.
109. Pfaff O, Gross J, Waelbroeck M, Mutschler E and Lambrecht G (1995) Functional characterization of muscarinic receptors in rat duodenum (abstract). Life Sci 56:1038.
110. Proska J and Tucek S (1995) Competition between positive and negative allosteric effectors on muscarinic receptors. Mol Pharmacol 48:696-702.
111. 5/m5 receptor subtype: Fact or fiction. Life Sci 60:1105-1112.
112. Richards MH and Van Giersbergen PL (1995) Human muscarinic receptors expressed in A9L and CHO cells: Activation by full and partial agonists. Br J Pharmacol 114:1242-1249.
113. Riker WF and Wescoe WC (1951) The pharmacology of flaxedil with observations on certain analogs. Ann NY Acad Sci 54:373-394.
114. Role LW and Berg DK (1996) Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16:1077-1085.
115. Roszkowski AP (1961) An unusual type of sympathetic ganglionic stimulant. J Pharmacol Exp Ther 132:156-170.
116. Rouse ST, Thomas TM and Levey AI (1997) Muscarinic acetylcholine receptor subtype, m2: Diverse functional implications of differential synaptic localization. Life Sci 60:1031-1038.
117. 1 receptor-mediated responses. Life Sci 54:305-310.
118. Savarese TM, Wang CD and Fraser CM (1992) Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor: Role of conserved cysteines in receptor function. J Biol Chem 267:11439-11448.
119. Shannon HE, Womer DE, Bymaster FP, Calligaro DP, Delapp NC, Mitch NC, Ward JS, Whitesitt CA, Swedberg MDB, Sheardown MJ, Fink-Jensen A, Olesen PB, Rimvall K and Sauerberg P (1997) In vivo pharmacology of butylthio[2,2,2] (LY297802/NNC11-1053), an orally acting antinociceptive muscarinic agonist. Life Sci 60:969-976.
120. Shapiro RA, Wakimoto BT, Subers EM and Nathanson NM (1989) Characterization and functional expression in mammalian cells of genomic and cDNA clones encoding a Drosophila muscarinic acetylcholine receptor. Proc Natl Acad Sci USA 86:9039-9043.
121. Sharma VK, Colecraft HM, Rubin LE and Sheu S-S (1997) Does mammalian heart contain only the M2 muscarinic receptor subtype? Life Sci 60:1023-1029.
122. Soejima M and Noma A(1984) Mode of regulation of the ACh-sensitive K-channel by the muscarinic receptor in rabbit atrial cells. Pflugers Arch 400:424-431.
123. Spalding TA, Birdsall NJM, Curtis CAM and Hulme EC (1994) Acetylcholine mustard labels the binding site aspartate in muscarinic acetylcholine receptors. J Biol Chem 269:4092-4097.
124. Stockton JM, Birdsall NJM, Burgen AS and Hulme EC (1983) Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol 23:551-557.
125. 2 muscarinic receptor in smooth muscle of guinea pig ileum. Mol Pharmacol 44:102-110.
126. Tietje KM and Nathanson NM (1991) Embryonic chick heart expresses multiple muscarinic acetylcholine receptor subtypes: Isolation and characterization of a gene encoding a novel m2 muscarinic acetylcholine receptor with a high affinity for pirenzepine. J Biol Chem 266:17382-17387.
127. Tucek S, Musilkova J, Nedoma J, Proska J, Shelkovnikov S and Vorlicek J (1990) Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors. Mol Pharmacol 38:674-680.
128. Vanhoutte PM, Humphrey PPA and Spedding M (1998) NC-IUPHAR receptor nomenclature criteria. Pharmacol Rev, in press.
129. Van Koppen CJ and Nathanson NM (1990) Site-directed mutagenesis of the m2 muscarinic acetylcholine receptor: Analysis of the role of N-glycosylation in receptor expression and function. J Biol Chem 265:20887-20892.
130. Van Zwieten PA and Doods HN (1995) Muscarinic receptors and drugs in cardiovascular medicine. Cardiovasc Drugs Ther 9:159-167.
131. Vasudevan S, Hulme EC, Bach M, Haase W, Pavia J and Reilander H (1995) Characterization of the rat m3 muscarinic acetylcholine receptor produced in insect cells infected with recombinant baculovirus. Eur J Biochem 227:466-475.
132. Vilaro MT, Palacios JM and Mengod G (1994) Multiplicity of muscarinic autoreceptor subtypes? Comparison of the distribution of cholinergic cells and cells containing mRNA for five subtypes of muscarinic receptors in the brain. Mol Brain Res 21:30-46.
133. Vogel WK, Mosser VA, Bulseco DA and Schimerlik MI (1995) Porcine m2 muscarinic acetylcholine receptor-effector coupling in Chinese hamster ovary cells. J Biol Chem 270:15485-15493.
134. Voith G and Dingermann T (1995) Expression of CSA-hm2 fusion in Dictyostelium discoideum under the control of the Dictyostelium ras promoter reveals functional muscarinic receptors. Pharmazie 50:758-762.
135. Waelbroeck M, Camus J, Tastenoy M, Feifel R, Mutschler E, Tacke R, Strohmann C, Rafeiner K, Rodrigues de Miranda JF and Lambrecht G (1994) Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes. Br J Pharmacol 112:505-514.
136. Waelbroeck M, Tastenoy M, Camus J and Christrophe J (1990) Binding of antagonists to four muscarinic receptors (M1-M4) in rat forebrain. Mol Pharmacol 38:267-273.
137. Wall S, Yasuda RP, Hory F, Flagg S, Martin BM, Ginns EL and Wolfe BB (1991a) Production of antisera selective for m1 muscarinic receptors using fusion proteins: Distribution of m1 receptors in the brain. Mol Pharmacol 39:643-649.
138. Wall S, Yasuda RP, Li M and Wolfe BB (1991b) Development of an antiserum against m3 muscarinic receptors: Distribution of m3 receptor in rat tissues and clonal cell lines. Mol Pharmacol 40:783-789.
139. Watson N, Daniels DV, Ford APDW, Eglen RM and Hegde SS (1998) Comparative pharmacology of human muscarinic m3 and m5 cholinoreceptors expressed in Chinese hamster ovary cells (abstract). Br J Pharmacol, 123:268P.
140. Watson N, Reddy H and Eglen RM (1995) Pharmacological characterization of the muscarinic receptors mediating contraction of canine saphenous vein. J Auton Pharmacol 15:437-441.
141. Weiner DM, Levey AI and Brann MR (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87:7050-7054.
142. Wess J (1993) Molecular basis of muscarinic acetylcholine receptor function. Trends Pharmacol Sci 14:308-313.
143. Wess J (1996) Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10:69-99.
144. Wess J, Bonner TI, Dörje F and Brann MR (1990) Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers. Mol Pharmacol 38:517-523.
145. Wess J, Gdula D and Brann MR (1992) Structural basis of the subtype selectivity of muscarinic antagonists: A study with chimeric m2/m5 muscarinic receptors. Mol Pharmacol 41:369-374.
146. Wess J, Liu J, Blin N, Yun J, Lerche C and Kostenis E (1997) Structural basis of receptor/G protein coupling selectivity studied with muscarinic receptors as model systems. Life Sci 60:1007-1014.
147. Wess J, Liu J, Blüml K, Yun J, Schoneberg T and Blin N (1995) Mutational analysis of muscarinic receptors: Structural basis of ligand binding and G protein recognition, in Molecular Mechanisms of Muscarinic Acetylcholine Receptor Function (Wess J ed) pp 1-18, R. G. Landes, Austin.
148. Wickman K and Clapham DE (1995) Ion channel regulation by G proteins. Physiol Rev 75:865-885.
149. Yasuda RP, Ciesla W, Flores LR, Wall SJ, Li M, Satkus SA, Weisstein JS, Spagnola BV and Wolfe BB (1993) Development of antisera for m4 and m5 muscarinic cholinergic receptors: Distribution of m4 and m5 receptors in rat brain. Mol Pharmacol 43:149-157.
150. Zhu SZ, Wang SZ, Hu J and El-Fakahany EE (1994) An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. Mol Pharmacol 45:517-523.